Imatinib T6230
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
matinib is an inhibitor of the receptor tyrosine kinases c-Abl, Bcr-Abl, PDGFR, and c-Kit (IC50: 600/100/100 nM).
CAS nr:
152459-95-5
Purity:
98%
Molecular Weight:
493,6
SMILES:
CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1
Formula:
C29H31N7O
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Microbiology/Virology,Autophagy,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Cytoskeletal Signaling
Target:
PDGFR,PDGFR,SARS-CoV,Autophagy,c-Kit,Bcr-Abl,Bcr-Abl,Bcr-Abl
